NANOCARRIER CO LTD
Presenting
Wednesday, January 10, 2018 at 03:30 PM
Room
Victor's (32nd Floor)
Description
Established in 1996 in Tokyo, Japan, to apply new block copolymers to develop new medicines. Listed on the TSE Mothers in Mar 2008. A number of oncology programs are in global clinical development, including NC-6004 in PIII for pancreatic cancer and PII for NSCLC and other cancers. Micellar nanoparticles are the company’s key technology platform.
Ichiro Nakatomi, President & CEO will present at the 2018 J.P. Morgan Health care conference at 3:30pm on January 10 in the Emerging Markets Track, and is willing to take deeper dive at 1-on-1 investor meetings.
>>627
＞今年はプレゼンないのかな？
中冨社長のJPM18のプレゼンは現地時間１０日午後３時３０分~でございます。
NANOCARRIER CO LTD
Presenting
Wednesday, January 10, 2018 at 03:30 PM
Room
Victor's (32nd Floor)
Description
Established in 1996 in Tokyo, Japan, to apply new block copolymers to develop new medicines. Listed on the TSE Mothers in Mar 2008. A number of oncology programs are in global clinical development, including NC-6004 in PIII for pancreatic cancer and PII for NSCLC and other cancers. Micellar nanoparticles are the company’s key technology platform.
Ichiro Nakatomi, President & CEO will present at the 2018 J.P. Morgan Health care conference at 3:30pm on January 10 in the Emerging Markets Track, and is willing to take deeper dive at 1-on-1 investor meetings.
ttps://jpmorgan.metameetings.net/events/healthcare18/sessions/13887-nanocarrier-co-ltd